ADAMTS-15 expression in early-stage ‘androgen-responsive’ LNCaP prostate cancer cells only impacted on survival in vitro but caused reduced tumorigenesis in NOD/SCID mice compared to those expressing the catalytically-inactive mutant, which was not observed in castrated mice. This evidence concerns the gene ADAMTS15 and prostate cancer.